News | January 31, 2023
Alkem to launch novel antibiotic for MDR infections
Zidavi is recommended by the Infectious Disease Society of America
Zidavi is recommended by the Infectious Disease Society of America
Diagnostic imaging will become an increasingly vital process in healthcare
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
The company is pleased to report positive performances from all divisions this quarter. Growth in our research divisions, Discovery Services and the Dedicated Centres was solid
mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
Following successful completion of full set of clinical studies of proposed rituximab biosimilar candidate DRL_RI, Dr. Reddy’s will now prepare to file in the United States, European Union and other regions
Multilateral collaborations will serve to strengthen knowledge sharing to formulate framework for accessible, affordable, and quality healthcare
Subscribe To Our Newsletter & Stay Updated
